Dr. Deborah Beth Kulick is a Cambridge, Massachusetts based psychiatrist who is specialized in Child & Adolescent. Active license number of Dr. Deborah Beth Kulick is 231096 for Child & Adolescent in Massachusetts. Her current practice location is 1493 Cambridge St, Cambridge. Patients can reach her at 617-665-2629. Dr. Deborah Beth Kulick is M.D. in Child & Adolescent and her NPI number (Unique professional ID assigned by NPPES) is 1578641171. Dr. Deborah Beth Kulick has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Dr. Deborah Beth Kulick speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1578641171
NPI Enumeration Date:
01 Nov, 2006
NPI Last Update On:
05 Dec, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Deborah Beth Kulick are as mentioned below.
License Number
Specialization
State
Status
231096
Child & Adolescent
Massachusetts
Primary
231096
Psychiatry
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Deborah Beth Kulick 236 Cross St, Belmont, Massachusetts
Zip:
02478-4238
Phone Number:
617-935-1159
Patients can reach Dr. Deborah Beth Kulick at 1493 Cambridge St, Cambridge, Massachusetts or can call to book an appointment on 617-665-2629.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.